Skip to main content

Table 9 Cortactin immunoreaction between different studied groups

From: A collaborative immunohistochemical study of Drp1 and cortactin in the epithelial dysplasia and oral squamous cell carcinoma

Cortactin

Dysplastic epithelium

Primary tumor

Metastatic LN

 

N = 35

%

N = 35

%

N = 35

%

Weak

26

74.3

16

45.7

10

28.6

Moderate

7

20.0

10

28.6

9

25.7

Strong

2

5.7

9

25.7

16

45.7

 

p1 = 0.001*, p2 = 0.001*, p3 = 0.005*

  1. Used test: One-way ANOVA test.
  2. p1: The difference between dysplastic epithelium & primary tumor.
  3. p2: The difference between dysplastic epithelium & metastatic LNs.
  4. p3: The difference between primary tumor and metastatic LNs.